Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

SELL
$1.16 - $1.77 $1,392 - $2,124
-1,200 Reduced 9.22%
11,816 $15.7 Million
Q3 2024

Oct 16, 2024

BUY
$1.62 - $2.03 $2,702 - $3,386
1,668 Added 14.7%
13,016 $22.9 Million
Q2 2024

Aug 12, 2024

SELL
$1.62 - $2.85 $200 - $353
-124 Reduced 1.08%
11,348 $18.8 Million
Q1 2024

May 08, 2024

SELL
$1.6 - $2.48 $3,052 - $4,731
-1,908 Reduced 14.26%
11,472 $28.3 Million
Q4 2023

Jan 25, 2024

SELL
$1.66 - $2.41 $147 - $214
-89 Reduced 0.66%
13,380 $30.8 Million
Q3 2023

Nov 14, 2023

BUY
$1.55 - $3.31 $20,876 - $44,582
13,469 New
13,469 $32.2 Million

Others Institutions Holding TLRY

About Tilray Brands, Inc.


  • Ticker TLRY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 611,401,984
  • Market Cap $251M
  • Description
  • Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...
More about TLRY
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.